Aastrom Biosciences Inc (NASDAQ:ASTM)
CAPS Rating:
The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.
RSS Headlines
Fool UK
Recs
They will need time to get the studies done. This stuff works and very exciting to see it all come alive and make a lot of money investing....